Glenmark Pharmaceuticals Ltd NSE:GLENMARK:

  • GLENMARK PHARMA - UNIT ADVANCES MULTI-COUNTRY PHASE 3 TRIAL FOR TRASTUZUMAB REZETECAN IN PLATINUM-RESISTANT OVARIAN CANCER